LSI USA '25 Almost at Capacity: Register Today arrow-icon

LSI Alumni Funding Report January 2025

January was another impressive month of funding for the LSI Alumni, raising over $500 million in new capital across 12 new deals. Our monthly Alumni Funding Update features transactions made by these medical device startups and their investors, as well as links to our proprietary media and coverage of the companies themselves.

Companies featured in the January 2025 update include: 

Arcuro Medical 

Announced the initial close of its Series A funding round led by Varana Capital to support its next phase of growth. The company develops the SuperBall Meniscal Repair System, a knotless, all-suture, all-inside device designed to replicate inside-out tensioning of the meniscus.

Aspect Biosystems 

Secured $115M in a Series B funding round, led by Dimension, to further develop its bioprinted tissue therapeutics platform. The funds will be used to accelerate the clinical development of various regenerative medicine solutions.

CeQur 

Closed a $120M equity financing round to drive commercial growth. The funds will enable the company to increase access to its four-day wearable insulin delivery devices for individuals with diabetes.

EBAMed

Secured an investment from CDP Venture Capital as part of the PNRR (Piano Nazionale di Ripresa e Resilienza) and the Next Generation EU initiative. ​​The company is advancing CardioKit, an ultrasound imaging device designed for non-invasive treatment of cardiac arrhythmias.

Francis Medical 

Raised $80M in an oversubscribed Series C round to further develop its water vapor ablation therapy for kidney, prostate, and bladder cancer. The company will utilize the funds to support ongoing clinical trials and commercial scaling efforts.

GT Medical Technologies 

Secured $37M in a Series D round to broaden access to GammaTile for patients with operable brain tumors in the United States. The investment will also support ongoing clinical evidence development and commercial growth.

iotaMotion 

Secured Series B funding and shared that 25 centers in the United States now offer the iotaSOFT Insertion System. iotaSOFT is designed to provide slow, controlled insertion of cochlear implant electrode arrays.

Neuronoff 

Secured $5M in funding from the DoD and NIH to further develop its Injectrode neuromodulation technology. The DoD grant will fund a randomized controlled trial for neurogenic bladder treatment after spinal cord injury, while NIH funding will support preclinical research on overactive bladder treatment.

Onkos Surgical 

Received a $35M venture loan facility from Horizon Technology Finance. The company plans to use the proceeds of the loan to expedite manufacturing and commercialization of its NanoCept, an antibacterial coating technology for orthopedic implants.

Quibim 

Completed a $50M Series A funding round led by Asabys and Buenavista. These funds will be used to expand Quibim’s product pipeline and AI models and support its commercial growth efforts.

Robeauté 

Secured $28M to further develop its microrobotic solutions for neurosurgery. The funding will aid ongoing development, support preparations for human trials in 2026, and help establish U.S. operations in anticipation of FDA approval and market entry.

Zeto 

Raised $31M in a Series B funding round led by MindWorks Global (MWG). This funding will allow Zeto to grow its commercial and operational teams, accelerate growth, and enhance its ongoing research and development initiatives.

More News

Stay tuned for more updates as these medical technology companies continue to innovate and lead the way in the medtech industry. As we look forward to LSI USA '25 in Dana Point next March, these achievements remind us of the incredible progress being made in the medtech sector.

Funding_Report_-_January_2025_16-9
Free Download
The Complete LSI Alumni Funding Report
Get the complete spreadsheet, which features these eight new deals and one acquisition from medical technology companies in January of 2025, totaling over $500 million from the 2025 LSI Alumni Funding Report.